HEPATITIS C NEWS
- CDC Analysis Recommends Enhanced Acute Hepatitis C Surveillance
READ NEWS
- Clinical Virology Results from Telaprevir Phase 3 Study ADVANCE
READ NEWS
- Non response to peginterferon alfa and ribavirin in IL28B CC & CT patients can be overcome by high dose continuous interferon alfa-2b administration in combination with ribavirin for chronic hepatitis C
READ NEWS
- GI-5005 Therapeutic Vaccine Plus Peg-IFN/Ribavirin Improves Sustained Virologic Response Versus Peg-IFN/Ribavirin In Prior Non-Responders With Genotype 1 Chronic HCV Infection
READ NEWS
- Telaprevir in Combination with Peginterferon Alfa2a and Ribavirin for 24 or 48 weeks in Treatment-Naïve Genotype 1 HCV Patients who Achieved an Extended Rapid Viral Response: Final Results of Phase 3 ILLUMINATE Study
READ NEWS
- Response-Guided Therapy (RGT) with Boceprevir (BOC) + Peginterferon alfa-2b/Ribavirin (P/R) for Treatment-Naïve Patients with Hepatitis C Virus (HCV) Genotype (G) 1 Was Similar to a 48-Wk Fixed-Duration Regimen with BOC + P/R in SPRINT-2
READ NEWS
- Completely individualized treatment durations with peginterferon-alfa-2b and ribavirin in HCV genotype 1-infected patients and importance of IL28B genotype (INDIV-2 study)
READ NEWS
- Long-term Follow-up of Patients with Chronic Hepatitis C Treated with Telaprevir in Combination with Peginterferon Alfa-2a and Ribavirin: Interim Analysis of the EXTEND Study
READ NEWS
- Maintenance peginterferon (pegIFN) therapy to prevent hepatocellular carcinoma (HCC) in patients with advanced chronic hepatitis C: extended follow - up results from the HALT - C Trial
READ NEWS
- FDA Issues Guidance for Development of Directing-acting Antiviral Drugs for Hepatitis C
READ NEWS
- Highest Rates of Hepatitis C Virus Transmission Found in Egypt
READ NEWS
- Vertex hep C drug works on many in 24 weeks: Study
READ NEWS
- KERRY & HONDA: Disrupting a deadly disease
READ NEWS
- Hispanics And Asians Less Likely To Receive Liver Transplants
READ NEWS
- FDA Approves Rapid Test for Antibodies to Hepatitis C Virus
READ NEWS
- Vitamin A and Treatment
READ NEWS
- Efforts to Up Minority Organ Donations Show Success
READ NEWS
- Study Finds Beta Blockers Alone More Effective for First Variceal Bleeding
READ NEWS
- Antiviral Therapy during Compensated Cirrhosis Most Cost-Effective Approach Treatment
READ NEWS
- Study Finds Poor Compliance with Cirrhosis Surveillance Recommendations Less than 20% of Qualified Patients Are Regularly Monitored
READ NEWS
- Peginterferon alfa-2B and Ribavirin for Liver Transplant Patients Yields 30% HCV SVR
READ NEWS
- Modest" Results With Nitazoxanide for HCV Genotype 1 Nonresponders
READ NEWS
- Study Links Liver Transplantation to Accelerated Cellular Aging
READ NEWS
- FDA Considers Expanded Use of HCV Drugs
READ NEWS
- Liver Donations from Living Donors Increase 42% after Educational Intervention
READ NEWS
- Infectious Disease Screening
READ NEWS
- Telaprevir Raises Response Rates in Hepatitis C
READ NEWS
- HCV Polymerase Inhibitor VX-222 Demonstrates Good Safety and Antiviral Activity in Treatment-naive Genotype 1 Hepatitis C Patients
READ NEWS
- HCV Protease Inhibitor Danoprevir (RG7227/ITMN-191) Shows Antiviral Activity at Lower Doses When Boosted with Ritonavir
READ NEWS
- HCV Protease Inhibitor Boceprevir Demonstrates Durable Sustained Response with No Late Relapse
READ NEWS
- Vertex Will Study All-Oral Regimen of HCV Protease Inhibitor Telaprevir plus Polymerase Inhibitor VX-222
READ NEWS
- U.S. Doctors Sanction Transplant Criteria for Liver Cancer Patients
READ NEWS
- Vertex Broadens its Commitment to Improving HCV Care with Clinical Trial to Evaluate Combination Regimens Based on Oral Antiviral Therapies
READ NEWS
- Is One Type of Pegylated Interferon More Effective for Treating Chronic Hepatitis C?
READ NEWS
- Hepatitis and Liver Cancer: A National Strategy for
Prevention and Control of Hepatitis B and C
READ NEWS
- Liver Donations from Living Donors Increase 42% after Educational Intervention
READ NEWS
- Vaccines May Lower Viral Load Improve Treatment Response
READ NEWS
- African Americans Fare Worse After Undergoing Liver Transplantation Due to Hepatitis C
READ NEWS
- Metabolic Factors That Predict Rapid Virologic Response to Peginterferon/Ribavirin in HCV Patients
READ NEWS
- Weight Loss: A Modifiable Lifestyle Parameter That Can Alter HCV Liver Disease Progression
READ NEWS
- Silent Epidemic of Viral Hepatitis May Lead to Boom in Serious Liver Disease
READ NEWS
- Direct Antivirals Can Beat HCV Without Interferon
READ NEWS
- HCV Response Linked Strongly to Gene Variant
READ NEWS
- Schering-Plough Reports Potent Antiviral Activity With Narlaprevir (SCH 900518), An Investigational, Once-Daily Protease Inhibitor For Hepatitis C
READ NEWS
- More Than 80 Percent Of HCV Genotype 1 Treatment-Naive Patients Achieved Sustained Virologic Response With Twice-Daily Telaprevir-Based Regimen
READ NEWS
- Sprint 1 Study, Phase 2, Boceprevir
READ NEWS
- Pegylated Interferon Lambda Demonstrates Good Antiviral Activity, May Cause Fewer Side Effects than Interferon Alfa
READ NEWS
- Coffee Could Stall Liver Disease Progression
READ NEWS
- Hepatitis C Drug Development at a Crossroads - Comments from the Editors
READ NEWS
- Hypertension and Diabetes Are Concern in Long-Term Care of Liver Transplant Patients
READ NEWS
- The FDA has just issued new warnings in the package inserts for alpha interferons
READ NEWS
- Women, Blacks, Medicare Recipients Less Likely To Be Evaluated For Liver Transplantation
READ NEWS
- New Biomarker Predicts Response to Hepatitis C Treatment
READ NEWS
- Protein & Cholesterol May Increase Risk Of Cirrhosis & Hepatocellular Carcinoima
READ NEWS
- Weight-Related Factors Tied to Outcomes of Chronic Hepatitis C
READ NEWS
- Head-to-Head Trial Finds HCV Regimens Equal
READ NEWS
- Interferon and Ribavirin Second-Line Option for Hepatitis C
READ NEWS
- DDW: Interferon Has Long-Term Histo Benefits in HCV
READ NEWS
- FDA May Restrict Acetaminophen
READ NEWS
- Detectable HCV RNA at Week 8 Is Best Predictor of Relapse in Genotype 1
READ NEWS
- DDW: Telaprevir Improves HCV Clearance in Resistant Patients
READ NEWS
- Hypothyroidism In Women Associated With Liver Cancer
READ NEWS
- Sustained Response Seen with New Hepatitis C Drug
READ NEWS
- Re-treatment of Chronic Hepatitis C Patients Who Do Not Respond to Pegylated Interferon Alfa-2b (PegIntron)
READ NEWS
- Promising Promising Early Results from the First Clinical Trial of a Combination Regimen of 2 Oral Antiviral Agents for Chronic Hepatitis C
READ NEWS
- Necessities of Interferon Therapy in Elderly Patients with Chronic Hepatitis C
READ NEWS
- HCV Vaccine Development
READ NEWS
- Pegylated Interferon alfa-2a (Pegasys) Relapse Rates in Genotype 1 Chronic Hepatitis C Patients Depend on Weight-based Ribavirin Dosage
READ NEWS
- Overview of the Current Standard of Care for Treatment of Chronic Hepatitis C
READ NEWS
- Response To Therapy In Chronic Hepatitis C Predicted By 2-Day Results
READ NEWS
- Vertex Acquires VCH-222 and VCH-759, Two Experimental Oral HCV Polymerase Inhibitors
READ NEWS
- Hepatitis C Linked to Increased Risk of Intrahepatic Cholangiocarcinoma
READ NEWS
- Liver Biopsies Indicate Persistent Inflammation and Fibrosis in HCV Antibody Positive People with Undetectable HCV RNA
READ NEWS
- Pharmasset and Roche Obtain FDA Consent to Start a Phase 2b Study with R7128 in Treatment Naive HCV Patients
READ NEWS
- Human Genome Sciences Announces Initiation of Phase 2b Trial 0f Albuferon Dosed Monthly in Chronic Hepatitis C
READ NEWS
- Although Hepatitis C Treatment Reduces The Virus, Liver Damage Continues
READ NEWS
- Human Genome Sciences Announces Albuferon(R) Meets Primary Endpoint In Phase 3 Trial In Chronic Hepatitis C
READ NEWS
- Pegylated interferon alpha2a is more effective in some hepatitis C patients with specific genotypes than the alpha2b form of the drug, an Italian researcher said
READ NEWS
- HCV Polymerase Inhibitor R7128 Demonstrates Good Antiviral Activity in Genotype 2 or 3 Prior Non-responders and Relapsers
READ NEWS
- Hepatitis C patients may have abnormal blood sugar
READ NEWS
- FDA Approves Nexavar for Patients with Inoperable Liver Cancer
READ NEWS
- Sustained Virological Response to Pegylated Interferon Alfa-2b (PegIntron) with or without Ribavirin Predicts Continued Response through 5 Years
READ NEWS
- Symptoms and Response to Interferon plus Ribavirin in Children with Chronic Hepatitis C
READ NEWS
- Safety and Activity of Once-Monthly Albinterferon Alfa-2b (Albuferon) in Genotype 2/3 Chronic Hepatitis C Patients
READ NEWS
- Insulin Resistance Independently Associated With Chronic Hepatitis C
READ NEWS
- Pathology of Chronic Hepatitis C in Children: Peds-C Trial
READ NEWS
- Silymarin (Milk Thistle) Does Not Affect Hepatitis C Virus Activity or ALT Levels in HCV Patients, but Users Report Fewer Symptoms and Better Quality of Life than Non Users
READ NEWS
- Acute Hepatitis C Infection and Spontaneous Viral Clearance in Adults and Children
READ NEWS
- How Effective Is Pegylated Interferon plus Ribavirin for HCV Genotype 1 Patients Over Age 50?
READ NEWS
- Depression Due to Treatment with Pegylated Interferon plus Ribavirin May Be Under-diagnosed by Clinicians
READ NEWS
- HALT-C Trial Shows Minimal Long-term Benefit of Pegylated Interferon Alfa-2a (Pegasys) Maintenance Therapy in Patients with Chronic Hepatitis C
READ NEWS
- Use of Epoetin (EPO) to Manage Anemia in Chronic Hepatitis C Patients Treated with Pegylated Interferon plus Ribavirin
READ NEWS
- Incidence and Predictors of Hepatocellular Carcinoma in Patients With Cirrhosis
READ NEWS
- HCV Care by Liver Specialists or Community-Based Practices: Pro & Con
READ NEWS
- Decreased HCV-specific Immunity in African-Americans May Help Explain Poorer Response to Antiviral Therapy
READ NEWS
- 400,000 IU/mL Is the Optimal Baseline Viral Load Cut-off to Predict Response In Treatment-naive Patients with Genotype 1 HCV
READ NEWS
- Liver Stiffness Predicts Portal Hypertension in HCV Cirrhosis
READ NEWS
- EASL: Sustained Virologic Response Equals Cure for HCV Infection
READ NEWS
- Racial Differences Seen In Steatosis In Patients With Hepatitis C
READ NEWS
- New Vaccine Schedule Offers Protection Against Hepatitis A And Hepatitis B
READ NEWS
- Interferon Gamma Does Not Reverse Fibrosis in Hepatitis C Patients with Advanced Liver Disease
READ NEWS
- Hepatitis C in African Americans
READ NEWS
- Three Studies Examine Syringe Exchange Policies in the U.S.
READ NEWS
- Short-course Pegylated Interferon for Acute Hepatitis C
READ NEWS
- Heavy-Drinking Women with HCV Infection Cut Decade Off Life
READ NEWS
- Treatment Response in Cirrhotic Hepatitis C Patients with Portal Hypertension
READ NEWS
- Integrating Medical and Mental Health Care Improves Likelihood of Initiation and Adherence to Hepatitis C Treatment
READ NEWS
- Rapid Decline of HCV RNA in Patients Treated with VX-950
READ NEWS
- Predicting Survival After Liver Transplant
READ NEWS
- Patients Who Recover from Hepatitis C Have Lower Risk of Reinfection
READ NEWS
- New Therapy Significantly Increases Platelet Count
READ NEWS
- Is Hepatitis A and B Screening and Vaccination in Chronic Hepatitis C Patients Effective?
READ NEWS
- Sustained Virological Response to PegIntron Plus Ribavirin in Asian and Hispanic Patients
READ NEWS